Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Daniel Clair, MD

216.444.4508

Daniel Clair, MD
Department: Vascular Surgery
Department Chair
Location: Cleveland Clinic Main Campus
Mail Code F30
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.4508
DeskDesk:216.444.8079
WorkFax:216.636.1002
Surgeon:
Yes
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Daniel Clair, MD, is Chairman of the Department of Vascular Surgery and a Vascular Surgeon practicing at Cleveland Clinic's main campus. Dr. Clair is board-certified in general and vascular surgery. He specializes in carotid artery surgery, thoraco-abdominal aortic repair/reconstruction, thoracic aortic aneurysm repair, abdominal aortic aneurysm repair, peripheral artery/vein repair/bypass surgery, aortic aneurysm stent repair, endovascular stent repair, thoracic outlet syndrome and chronic venous occlusive disease.

Dr. Clair received his medical degree from the University of Virginia School of Medicine in Charlottesville, Va., where he was inducted into the medical honor society Alpha Omega Alpha. He took his internship and residency in surgery at Brigham and Women’s Hospital in Boston, becoming Chief Resident in Surgery and receiving the F.D. Moore Resident Teaching Award. Dr. Clair completed his training with clinical and research fellowships, among them a fellowship in clinical oncology from the American Cancer Society; a fellowship in vascular surgery from Brigham and Women’s Hospital in Boston, where he became an associate surgeon; and research fellowship as Research Scientist at VazoRx, Inc., in Woburn, Mass.

For four years, Dr. Clair was an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Md., completing his military service stationed at Andrews AFB, Md., as Chief of the Vascular Surgery Section. He has had a number of academic appointments including Clinical Fellow in Surgery at Harvard Medical School, where he was also Instructor in Surgery. He also taught at Columbia University College of Physicians and Surgeons as Assistant Professor of Surgery, where he served as the Chief of the Vascular Surgery Service, and at Weill Medical College of Cornell University, where he was Adjunct Assistant Professor of Surgery. Dr. Clair was appointed to the Cleveland Clinic as a vascular surgeon from 1998 to 2002. He returned to Cleveland Clinic in 2004, and was named Chairman/Program Director of the Department of Vascular Surgery in 2006.

Dr. Clair’s research interests have focused on clinical trials of minimally invasive vascular therapies. He has played a significant role in industry-sponsored clinical trials, most recently as the National Principal Investigator for the EMPIRE Trial in which researchers study a flow reversal system for carotid stenting. He is a Principal Investigator for the ORION trial assessing the performance of a new expandable stent used to treat iliac artery occlusive disease. He has been invited to present his research findings and clinical experience at more than 90 international and national medical conferences and symposia.

On the Editorial Board of the Journal of Vascular Surgery and the Editorial Advisory Board of Vascular Disease Management, Dr. Clair also serves as a reviewer for the Journal of Vascular Surgery, the Journal of Endovascular Therapy and the Annals of Vascular Surgery. He has authored or co-authored more than 60 articles and book chapters on his clinical experience and research.

Dr. Clair was named Distinguished Fellow of the Society of Vascular Surgery. He is a member of the Society for Clinical Vascular Surgery, the International Society for Vascular Surgery, the American Association for Vascular Surgery, the Eastern Vascular Society, the Midwestern Vascular Surgical Society, the Peripheral Vascular Surgical Society, the Stroke Council of the American Heart Association, the American College of Surgeons, the Ohio Chapter of the American College of Surgeons, the International Society for Endovascular Surgery, the Society of Air Force Clinical Surgeons and the Medical Society of Virginia.

Education & Fellowships

Fellowship - Brigham & Women's Hospital
Vascular Surgery
Boston, MA
1993
Residency - Brigham & Women's Hospital
Surgery
Boston, MA
1992
Medical School - University of Virginia School of Medicine
Charlottesville, VA USA
1986
Undergraduate - Hamilton College
Clinton, NY USA
1982

Certifications

  • Surgery- Vascular Surgery
  • Surgery

Specialty Interests

Aortic aneurysm, aorta surgery, bypass surgery for atherosclerosis/PAD/PVD, carotid endarterectomy, carotid stenting, endovascular aorta treatment, endovascular stent repair, mesenteric arteries occlusive disease, surgery for thoracic outlet syndrome, thoraco-abdominal-aneurysms treatment

Awards & Honors

  • Distinguished Fellow, Society for Vascular Surgery
  • National Principal Investigator - EMPIRE Trial
  • America's Top Doctors, 2007

Memberships

  • Society for Vascular Surgery
  • Midwestern Vascular Surgical Society
  • American College of Surgeons
  • Society for Clinical Vascular Surgery
  • Eastern Vascular Surgical Society

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/4/2013, Dr. Clair has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Clair receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Medtronic, Inc.
  • University of Arkansas
  • Vessix Vascular, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English